US 9956172
Implant compositions for the unidirectional delivery of therapeutic compounds to the brain
granted A61KA61K31/155A61K31/198
Quick answer
US patent 9956172 (Implant compositions for the unidirectional delivery of therapeutic compounds to the brain) held by The Board of Regents of the University of Texas System expires Mon Apr 26 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Board of Regents of the University of Texas System
- Grant date
- Tue May 01 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Apr 26 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 64
- CPC classes
- A61K, A61K31/155, A61K31/198, A61K31/282, A61K31/337